They focused on surgeries performed from the beginning of 2020 through 2024, including both initial weight loss surgeries and follow-up revision or conversion procedures procedures performed to modify or adjust earlier operations
Yes, many GLP-1 medications were originally developed for Type 2 diabetes
IQVIA Payer Control Library Coverage Is Broader, but Friction Persists The relative success of diabetes GLP-1s is largely due to more favorable coverage and disease framing
This is similar to Rybelsus, the oral semaglutide approved for diabetes (but not for weight loss)
Many other medications are also available as injector pens, including other injectable medicines for diabetes, high cholesterol, migraine prevention, and other monoclonal antibodies
Retatrutide takes this a step further by adding the Glucagon receptor, which targets metabolic ratea component previous peptides did not directly address